The clinical relevance of static disease (no change) category for 6 months on endocrine therapy in patients with breast cancer

This publication has 8 references indexed in Scilit:

• Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer
  The Breast, 1997
• Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up
  European Journal Of Cancer, 1992
• Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy
  European Journal of Cancer and Clinical Oncology, 1989
• The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast
  European Journal of Cancer and Clinical Oncology, 1988
• Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.
  BMJ, 1988
• Analysis of survival by tumor response.
  Journal of Clinical Oncology, 1983
• Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.
  BMJ, 1981
• Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland
  Cancer, 1977